T1	Participants 516 616	patients with small choroidal melanoma, not large enough to be eligible for the COMS clinical trials
T2	Participants 816 855	204 patients were enrolled in the study
T3	Participants 857 865	Patients
T4	Participants 1080 1088	patients
T5	Participants 1195 1216	Twenty-seven patients
T6	Participants 1228 1236	6 deaths
T7	Participants 235 243	patients
